2019
DOI: 10.1016/j.ejmech.2019.06.040
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of novel galeterone derivatives and evaluation of their in vitro activity against prostate cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 16 publications
0
12
0
Order By: Relevance
“…The target galeterone derivatives were obtained in good yields by heating under reflux in dry MeCN in the presence of p-TsOH (Scheme 17). 60 Under these conditions, in addition to the predominant aromatic products 60a-c, 60'c, D-homo-ketones 61a-c, 61'c were obtained which were formed as autoxidation products. In addition, from the mixture of derivatives 60c, 60'c and 61c, 61'c, the regioisomers were isolated as individual products.…”
Section: Scheme 12mentioning
confidence: 97%
See 2 more Smart Citations
“…The target galeterone derivatives were obtained in good yields by heating under reflux in dry MeCN in the presence of p-TsOH (Scheme 17). 60 Under these conditions, in addition to the predominant aromatic products 60a-c, 60'c, D-homo-ketones 61a-c, 61'c were obtained which were formed as autoxidation products. In addition, from the mixture of derivatives 60c, 60'c and 61c, 61'c, the regioisomers were isolated as individual products.…”
Section: Scheme 12mentioning
confidence: 97%
“…The values of the maximum inhibition 11). 60 Pyrimidobenzimidazole derivatives 70, 71 a-h 65 showed antibacterial activity with a MIC of 2 μg/ml against Grampositive bacteria and 1 μg/ml against Gram-negative bacteria. Compounds 70, 71 a-h showed antibacterial activity superior to ciprofloxacin against Enterococcus faecalis with a MIC of 0.2 to 0.8 μg/ml.…”
Section: Biological Activity Of Pyrimidobenzimidazole Derivativesmentioning
confidence: 99%
See 1 more Smart Citation
“…Androgen receptors and related signal pathways play an important role in prostate cancer cell proliferation and are the main target of androgen‐deprivation therapy [1]. Basic principles of prostate cancer therapy are using of androgen biosynthesis inhibitors (such as abiraterone), as well as androgen receptor antagonists (such as enzalutamide), and androgen receptor degraders [2–4]. It is known that prostate cancer cells are capable to express both full‐length androgen receptor and aberrant splicing forms of the receptor, including AR‐V7, associated with unfavorable outcome of the disease and resistance to abiraterone and enzalutamide [1–3].…”
Section: Introductionmentioning
confidence: 99%
“…Galeterone was also speculated to have higher selectivity toward 17,20‐lyase activity of CYP17A1 than abiraterone, which was indirectly confirmed by relatively small increase in corticosterone level in patients after galeterone administration for 12 weeks, compared to that of after therapy with abiraterone [7]. Despite clinical trials of galeterone being on hold, it was shown that the use of galeterone and its derivatives is a potentially effective therapeutic strategy for castrate‐resistant prostate cancer patients with found androgen receptor splice form AR‐V7 [1,3,8].…”
Section: Introductionmentioning
confidence: 99%